Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Shaanxi Panlong Pharmaceutical Group Co's
Operating Income
for the
three
months ended in Mar. 2026 was ¥36 Mil. Shaanxi Panlong Pharmaceutical Group Co's Interest Expense for the
three
months ended in Mar. 2026 was ¥-1 Mil.
Shaanxi Panlong Pharmaceutical Group Co's interest coverage for the quarter that ended in Mar. 2026 was 70.44.
The higher the ratio, the stronger the company's financial strength is.
Good Sign:
Ben Graham prefers companies' interest coverage to be at least 5. Shaanxi Panlong Pharmaceutical Group Co Ltd has enough cash to cover all of its debt. Its financial situation is stable.
SZSE:002864'
s Interest Coverage Range Over the Past 10 Years
Min: 8.96 Med: 44.65 Max: 846.06
Current: 64.05
SZSE:002864's Interest Coverage is ranked better than 73.94% of 687
companies
in the Drug Manufacturers industry
Industry Median: 12.75
vs SZSE:002864: 64.05
Shaanxi Panlong Pharmaceutical Group Co (SZSE:002864) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Shaanxi Panlong Pharmaceutical Group Co Interest Coverage Related Terms
Shaanxi Panlong Pharmaceutical Group Co Interest Coverage Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
Shaanxi Panlong Pharmaceutical Group Co Interest Coverage Chart
Shaanxi Panlong Pharmaceutical Group Co Annual Data
For the Drug Manufacturers - Specialty & Generic subindustry, Shaanxi Panlong Pharmaceutical Group Co's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shaanxi Panlong Pharmaceutical Group Co Interest Coverage vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Shaanxi Panlong Pharmaceutical Group Co's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Shaanxi Panlong Pharmaceutical Group Co's Interest Coverage falls into.
Shaanxi Panlong Pharmaceutical Group Co Interest Coverage Calculation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shaanxi Panlong Pharmaceutical Group Co (SZSE:002864) has a Interest Coverage of 70.44 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Shaanxi Panlong Pharmaceutical Group Co and its competitors. This is 58% above median its historical median of 44.65. Over the past decade, Shaanxi Panlong Pharmaceutical Group Co's Interest Coverage has ranged from 8.96 to 846.06. According to the industry distribution chart, Shaanxi Panlong Pharmaceutical Group Co ranks #179 out of 687 companies in the Drug Manufacturers industry, placing it in the top 26.1%.
Is Shaanxi Panlong Pharmaceutical Group Co's Interest Coverage too high?
Shaanxi Panlong Pharmaceutical Group Co's current Interest Coverage of 70.44 is 58% above median its 10-year median of 44.65. Over the past 10 years, this metric has ranged from a low of 8.96 to a high of 846.06. The Drug Manufacturers industry median Interest Coverage is 12.75. Shaanxi Panlong Pharmaceutical Group Co's value of 70.44 is 452.5% above this industry median. Based on the distribution chart, Shaanxi Panlong Pharmaceutical Group Co ranks #179 out of 687 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Shaanxi Panlong Pharmaceutical Group Co has a GF Score™ of 84/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Shaanxi Panlong Pharmaceutical Group Co's Interest Coverage compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Shaanxi Panlong Pharmaceutical Group Co ranks #179 out of 687 companies for Interest Coverage. This puts Shaanxi Panlong Pharmaceutical Group Co in the upper half of its industry. The industry median Interest Coverage is 12.75. Shaanxi Panlong Pharmaceutical Group Co's value of 70.44 is 452.5% above this benchmark. Historically, Shaanxi Panlong Pharmaceutical Group Co's own Interest Coverage has ranged from 8.96 to 846.06 over the past decade. While the company's 10-year median is 44.65 vs. the industry median of 12.75, Shaanxi Panlong Pharmaceutical Group Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Drug Manufacturers company?
The median Interest Coverage among Drug Manufacturers companies is 12.75, based on 687 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shaanxi Panlong Pharmaceutical Group Co's current Interest Coverage of 70.44 is 452.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Shaanxi Panlong Pharmaceutical Group Co and its competitors. For the Drug Manufacturers industry, the median Interest Coverage is 12.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shaanxi Panlong Pharmaceutical Group Co's current Interest Coverage is 70.44, which is 58% above median its own 10-year median of 44.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shaanxi Panlong Pharmaceutical Group Co stock overvalued right now?
Based on GuruFocus' analysis, Shaanxi Panlong Pharmaceutical Group Co (SZSE:002864) is currently considered Fairly Valued. The stock's GF Value™ is ¥24.66, compared to a current price of ¥22.86 — trading 7.3% below its estimated fair value. The current Interest Coverage is 70.44, which is 58% above median its 10-year median of 44.65 and 452.5% above the Drug Manufacturers industry median of 12.75. Shaanxi Panlong Pharmaceutical Group Co's overall GF Score™ is 84/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Shaanxi Panlong Pharmaceutical Group Co (SZSE:002864), the current Interest Coverage is 70.44 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shaanxi Panlong Pharmaceutical Group Co (SZSE:002864) Overvalued in 2026?
Based on GuruFocus' analysis, Shaanxi Panlong Pharmaceutical Group Co stock appears to be undervalued.
The current stock price of ¥22.86 is trading 7.3% below its estimated GF Value™ of ¥24.66.
GuruFocus considers Shaanxi Panlong Pharmaceutical Group Co to be Fairly Valued.
Key valuation signals for SZSE:002864:
Interest Coverage: 70.44 (58% above median its 10-year median of 44.65)
GF Value™: ¥24.66 vs. price of ¥22.86 (7.3% below fair value)
Industry Position: 452.5% above the Drug Manufacturers median (#179 of 687)
No single metric tells the full story. See the SZSE:002864 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shaanxi Panlong Pharmaceutical Group Co Ltd is engaged in the cultivation of medicinal herbs under Good Agricultural Practices (GAP), pharmaceutical production, research and development, sales, and logistics activities. Its business scope also includes technology and goods import and export, import and export agency services, medical research and experimental development, and the sale of hygiene products, disposable medical supplies, and disinfectants.
84GF Score
Get the complete analysis for SZSE:002864
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SZSE:002864 has been successfully added to your 
